Patent Challenge To US based Gilead Sciences for Hepatitis-C Medicines

Two oppositions in the Indian patent office are filed by the Patients’ rights advocates in India, challenging patent claims by the US pharmaceutical company Gilead Sciences for its medicines sofosbuvir…

CCI penalises Glenmark Pharma, other entities for unfair business practices

The Competition Commission on Friday imposed penalties totalling nearly Rs 47 crore on Glenmark Pharmaceutical, its three officials, two other pharma companies and four Gujarat-based chemists associations for indulging in…

Gennova Bio gets US drug patent to treat brain clots

MUMBAI: Decks have been cleared for a more affordable stroke treatment — developed by domestic company Gennova Biopharmaceuticals — to go global. The Pune-based biotech company has been granted a…

Pilot launched to confirm 10 cr Modicare beneficiary families

New Delhi, The National Health Agency (NHA) on Friday said it has launched a pilot for the Beneficiary Identification System (BIS) for confirmation of 10.74 crore poor and vulnerable families…

Fortis will grow stronger under IHH ownership: Singh brothers

NEW DELHI: Former Fortis promoters, Singh brothers Friday said the hospital chain will grow stronger under the new ownership of IHH Healthcare. Similarly, Munjals-Burmans combine which did not participate in…

National Health Agency (NHA) launches Beneficiary Identification System for Ayushman Bharat

New Delhi: The National Health Agency (NHA) under Ministry of Health and Family Welfare has launched pilot for Beneficiary Identification System (BIS). It is a process which will confirm application…

Malaysia’s IHH trumps Manipal to win Fortis Healthcare bid at Rs 170/share

The Board of Directors of Fortis Healthcare Limited has selected the binding investment proposal from Malaysia’s IHH Healthcare Berhad to invest Rs 4,000 crores by way of preferential allotment at…

Carbetocin will help in preventing postpartum haemorrhage: Suresh Pattathil

Shahid Akhter, editor, ETHealthworld spoke to Suresh Pattathil, CEO, Ferring India, Mumbai to know more about Carbetocin in the light of Champions Clinical Trial and its impact on Post- Partum…

At Sion hospital, ‘palatable’ oral pellets for HIV+ kids

MUMBAI: The long-standing demand for a more palatable form of HIV medicine for infants has finally been met with the National Aids Control Organisation (NACO) rolling out oral pellets in…

USD 550 million awarded in lawsuit linking cancer, baby powder

R St Louis (US): Nearly two dozen women who claimed asbestos in Johnson & Johnson talcum powder caused their ovarian cancer were awarded USD 550 million in damages by a…